M

Member

Speaking in the House of Lords on 11 November 2026

Debate

Health Bill

Contribution

We have become accustomed to thinking about health policy largely in terms of what happens when someone becomes ill and what treatment the NHS can provide, rather than all the other factors that make up our health. Of course, many businesses make a positive contribution to public health; others make money from products and practices that damage it. We need to understand that influence and make sure that it does not shape government policy. Those interests are there. A study of parliamentary groups found that pharma companies and industry-funded patient organisations provided more than £2.1 million to health-related APPGs, accounting for 30% of their total funding. People are always trying to strengthen the rules around APPGs, but there is a responsibility for the Government to make sure that the influence being put on them and the way they are considering and making decisions is not unduly commercially influenced. This is not or should not be a controversial principle, but it is one that needs to be actively protected.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.